Is Mounjaro or Semaglutide Better for Weight Loss?

Last reviewed: June 9, 2026

Last updated: June 9, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Both tirzepatide and semaglutide are GLP-1 receptor agonists that help people lose weight by reducing hunger signals and slowing stomach emptying. However, tirzepatide activates two hormone pathways instead of one, which may produce different results depending on your genetic makeup and metabolic profile.

How Semaglutide Works for Weight Loss

Semaglutide mimics glucagon-like peptide-1 (GLP-1), a natural hormone that tells your brain you are full. By activating GLP-1 receptors in the hypothalamus and other appetite centers, semaglutide reduces calorie intake by suppressing hunger cues. The medication also slows gastric emptying, meaning food stays in your stomach longer and triggers prolonged satiety signals.

Clinical trials show that semaglutide users lose an average of 10–15% of body weight over 68 weeks when combined with lifestyle changes. The single-pathway mechanism makes it straightforward for many patients, though individual responses vary based on how strongly their GLP-1 receptors respond to stimulation.

Tirzepatide's Dual-Pathway Mechanism for Weight Management

Tirzepatide activates both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, creating a dual-hormone effect in the brain and body. This two-pathway activation may produce stronger appetite suppression and more stable blood sugar control compared to single-receptor agents. Patients using tirzepatide experience reduced hunger through multiple signaling channels simultaneously.

Phase 3 clinical trials demonstrate that tirzepatide users lose 20–22% of body weight over 72 weeks at maximum doses, outpacing semaglutide results in head-to-head comparisons. The enhanced weight loss may reflect the additional GIP-pathway activity, though not all patients respond identically—genetic variation in GIP and GLP-1 receptor genes influences individual outcomes.

Genetic Factors That Determine Your Best Treatment

Your DNA influences how effectively you respond to tirzepatide or semaglutide. Key genetic variants in GIPR gene (rs1800437) determine how many functional receptors you have and how efficiently they bind these medications. Patients carrying specific variant combinations may respond better to one therapy than the other.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Choosing Between Tirzepatide and Semaglutide at PlexusDx

PlexusDx offers both compounded semaglutide injection (at $189/mo month-to-month, or from $149/mo on the 6-month plan) and compounded tirzepatide injection (at $289/mo month-to-month, or from $249/mo on the 6-month plan) from licensed 503A pharmacies. Both medications are available across all 50 states with no insurance requirement, and doses may increase as your treatment progresses—but PlexusDx pricing remains flat at your tier level.

Many patients benefit from starting with genetic insights: the Precision Peptide Genetic Test ($298) reveals whether your genetics favor tirzepatide's dual pathway or semaglutide's focused GLP-1 approach. This personalized data helps your provider select the therapy with the highest probability of success, reducing trial-and-error treatment adjustments.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Does tirzepatide always produce more weight loss than semaglutide?

Clinical trials show tirzepatide averages greater weight loss overall, but individual responses vary significantly. Some patients achieve excellent results with semaglutide alone, while others benefit more from tirzepatide's dual-pathway activation. Your genetic makeup—particularly GIPR variants—influences which medication aligns better with your metabolism.

What is the main difference between these medications?

Semaglutide activates only GLP-1 receptors, while tirzepatide activates both GLP-1 and GIP receptors. This dual activation in tirzepatide may produce stronger appetite suppression and metabolic effects in some patients. The choice depends on your health goals, genetic profile, and how your body responds to each pathway.

How much does compounded tirzepatide cost at PlexusDx?

PlexusDx compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan) and remains flat across commitment tiers—your dose may increase as treatment progresses, but your price won't. All medications are HSA/FSA eligible, served nationwide without insurance requirements or membership fees.

Are side effects different between tirzepatide and semaglutide?

Both medications commonly cause nausea, vomiting, and diarrhea, especially during dose escalation. Tirzepatide's dual-pathway activation may produce slightly different side effect patterns in some patients. Individual tolerability varies based on genetics, dose, and personal sensitivity; most side effects diminish over time as your body adjusts.

How does the Precision Peptide Genetic Test help me choose?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GIPR (rs1800437)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Semaglutide For Weight Loss 2
• Mounjaro For Weight Loss 2
• Weight Loss Mounjaro
• Mounjaro Weight Loss By Week

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.